R J Biotech Limited announced earnings results for the half and full year ended March 31, 2021. For the half year, the company announced total revenue of INR 22.613 million against INR 29.355 million a year ago. Net loss was INR 5.224 million compared to INR 2.227 million a year ago. Basic loss per share from continuing operations was INR 1.11 compared to INR 9.55 a year ago. For the full year, the company announced total revenue was INR 157.961 million compared to INR 134.978 million a year ago. Net loss was INR 156.818 million compared to INR 41.563 million a year ago. Basic loss per share from continuing operations was INR 16.56 compared to INR 4.39 a year ago.